Robert F Ritchie
Overview
Explore the profile of Robert F Ritchie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ritchie R, Ledue T, Craig W
Clin Chem Lab Med
. 2007 Feb;
45(2):158-66.
PMID: 17311501
Movement of body water from compartment to compartment during any time period is attributable to forces active within and upon each space. The result of these forces leads to transfer...
2.
Craig W, Ledue T, Collins M, Meggison W, Leavitt L, Ritchie R
Clin Chem Lab Med
. 2006 Oct;
44(10):1283-6.
PMID: 17032143
Background: There are currently no guidelines concerning additional laboratory testing for specific autoantibodies among anti-nuclear antibody-negative sera with an anti-cytoplasmic staining pattern identified by indirect immunofluorescence assay. Moreover, few data...
3.
Ritchie R, Palomaki G, Neveux L, Ledue T, Marcovina S, Navolotskaia O
J Clin Lab Anal
. 2006 Sep;
20(5):218-26.
PMID: 16960899
Limiting the clinical utility of apolipoproteins AI (apo AI) and B (apo B) and the apo B/AI ratios until the last decade has been the lack of satisfactory methods for...
4.
Ritchie R, Palomaki G, Neveux L, Ledue T, Craig W, Marcovina S, et al.
J Clin Lab Anal
. 2006 Sep;
20(5):209-17.
PMID: 16960896
The two serum apolipoproteins in the highest concentrations, apolipoprotein (apo) AI and apolipoprotein B, and the apolipoprotein B/AI ratio are measured to assess clinical risk for atherosclerotic heart and peripheral...
5.
Ritchie R, Palomaki G
Clin Chem Lab Med
. 2004 Aug;
42(7):702-9.
PMID: 15327003
The selection of individuals to represent a group for any purpose can commit the effort to success or failure from the very outset. The description of this group must reflect...
6.
Ritchie R, Palomaki G, Neveux L, Navolotskaia O
J Clin Lab Anal
. 2004 Apr;
18(2):148-52.
PMID: 15065216
The lack of satisfactory methods for quantifying serum levels and a credible reference material has limited bedside use of serum alpha(2)-macroglobulin (alpha2M) measurements. Great strides have been made in the...
7.
Ritchie R, Palomaki G, Neveux L, Navolotskaia O, Ledue T, Craig W
J Clin Lab Anal
. 2004 Apr;
18(2):139-47.
PMID: 15065215
In this 11th article in a series, reference values of serum levels alpha(2)-macroglobulin alpha(2)M) are examined. The study is based on a cohort of 40,420 Caucasian individuals from northern New...
8.
Ritchie R, Palomaki G, Neveux L, Navolotskaia O
J Clin Lab Anal
. 2004 Jan;
18(1):9-13.
PMID: 14730551
The lack of credible reference materials and satisfactory methods for quantifying serum levels has limited the bedside use of complement protein (C3 and C4) measurements. However, great technological strides have...
9.
Ritchie R, Palomaki G, Neveux L, Navolotskaia O, Ledue T, Craig W
J Clin Lab Anal
. 2004 Jan;
18(1):1-8.
PMID: 14730550
The two serum proteins of the complement cascade in the highest concentrations, C3 and C4, respond to various conditions in much the same manner as do other positive acute-phase proteins....
10.